Publications: Maker, Garth
Abbiss, H., Rawlinson, C., Maker, G.L. and Trengove, R. (2015) Assessment of automated trimethylsilyl derivatization protocols for GC–MS-based untargeted metabolomic analysis of urine. Metabolomics, 11 (6). pp. 1908-1921.
Wong, H.S., Maker, G.L., Trengove, R.D. and O'Handley, R.M. (2015) Gas chromatography-mass spectrometry-based metabolite profiling of Salmonella enterica serovar typhimurium differentiates between biofilm and planktonic phenotypes. Applied and Environmental Microbiology, 81 (8). pp. 2660-2666.
Wenner, M.I., Maker, G.L., Dawson, L.F., Drummond, P.D. and Mullaney, I. (2015) The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells. Cytotechnology (In Press). pp. 1-15.
Lopresti, A.L., Maes, M., Meddens, M.J.M., Maker, G.L., Arnoldussen, E. and Drummond, P.D. (2014) Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change. European Neuropsychopharmacology, 25 (1). pp. 38-50.
Lopresti, A.L., Maes, M., Maker, G.L., Hood, S.D. and Drummond, P.D. (2014) Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167 . pp. 368-375.
King, G., Damas, J.E., Cake, M.H., Berryman, D. and Maker, G.L. (2014) Influence of glucocorticoids, neuregulin-1 , and sex on surfactant phospholipid secretion from type II cells. AJP: Lung Cellular and Molecular Physiology, 306 (3). L292-L298.
King, G., Maker, G.L., Berryman, D., Trengove, R.D. and Cake, M.H. (2014) Role of neuregulin-1β in dexamethasone-enhanced surfactant synthesis in fetal type II cells. FEBS Letters, 588 (6). pp. 975-980.
Lopresti, A.L., Maker, G.L., Hood, S.D. and Drummond, P.D. (2014) A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 48 . pp. 102-111.
De Meyer, S.E., Cnockaert, M., Ardley, J.K., Maker, G., Yates, R., Howieson, J.G. and Vandamme, P. (2013) Burkholderia sprentiae sp. nov. isolated from Lebeckia ambigua root nodules. International Journal of Systematic and Evolutionary Microbiology, 63 (11). pp. 3950-3957.
Murdoch, F.R., Maker, G.L., Nitsos, I., Polglase, G.R. and Musk, G.C. (2013) Intraperitoneal medetomidine: a novel analgesic strategy for postoperative pain management in pregnant sheep. Laboratory Animals, 47 (1). pp. 66-70.
Ng-Hublin, J.S.Y., Ryan, U., Trengove, R. and Maker, G. (2013) Metabolomic profiling of faecal extracts from cryptosporidium parvum infection in experimental mouse models. PloS one, 8 (10). e77803.
Maker, G.L., Siva, B., Batty, K.T, Trengove, R.D., Ferrari, P. and Olynyk, J.K. (2013) Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis. Nephrology, 18 (3). pp. 188-193.
Abbiss, H., Maker, G.L., Gummer, J., Sharman, M., Phillips, J.K., Boyce, M. and Trengove, R.D. (2012) Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease. Nephrology, 17 (2). pp. 104-110.
Ng, J.S.Y., Ryan, U., Trengove, R.D. and Maker, G.L. (2012) Development of an untargeted metabolomics method for the analysis of human faecal samples using Cryptosporidium-infected samples. Molecular and Biochemical Parasitology, 185 (2). pp. 145-150.
Musk, G.C., Netto, J.D., Maker, G.L. and Trengove, R.D. (2012) Transplacental transfer of medetomidine and ketamine in pregnant ewes. Laboratory Animals, 46 (1). pp. 46-50.
Netto, J.D., Musk, G.C., Maker, G.L. and Trengove, R.D. (2011) Liquid chromatography tandem mass spectrometry for the simultaneous quantitative analysis of ketamine and medetomidine in ovine plasma. Biomedical Chromatography, 25 (12). pp. 1374-1380.
Wong, H.S., Townsend, K.M., Fenwick, S.G., Maker, G.L., Trengove, R.D. and O'Handley, R.M. (2010) Comparative susceptibility of Salmonella Typhimurium biofilms of different ages to disinfectants. Biofouling, 26 (7). pp. 859-864.
Tan, K.C., Trengove, R.D., Maker, G.L., Oliver, R.P. and Solomon, P.S. (2009) Metabolite profiling identifies the mycotoxin alternariol in the pathogen Stagonospora nodorum. Metabolomics, 5 (3). pp. 330-335.
Hong, I., Maker, G., Mullaney, I., Garrett, A., Rodger, J. and Etherington, S. (2014) Pulsed magnetic fields modulate neuronal primary metabolites in vitro. In: Meeting of the Australasian Neuroscience Society, 28 - 31 January, Adelaide, SA, Australia.
Wenner, M.I., Maker, G.L., Etherington, S.J., Drummond, P.D. and Mullaney, I. (2013) Metabolomics as a tool to investigate α-adrenergic recept-mediated signaling in cortical neurons. In: Australian Neuroscience Society Annual Meeting, 29 January - 1 February, Gold Coast, Australia.
Shaw, J.A., Maker, G.L., Brooker, L.R. and Clode, P.L. (2009) The chiton fauna of the Swan River Estuary and their potential role as indicators of environmental contamination. In: Swan Canning Research and Innovation Program Showcase, 19 August, Perth, Western Australia.
Maker, Garth Lucas (2008) Regulation of surfactant production by fetal type II pneumocytes and the characterization of fibroblast-pneumocyte factor. PhD thesis, Murdoch University.